A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease

Clinical trial NCT02218099 · COMPLETED

Trial details

NCT number: NCT02218099
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Subjects Pharmacokinetics of ASP8232 Pharmacodynamics of ASP8232 Chronic Kidney Disease (CKD)Type 2 Diabetes Mellitus (T2DM)

Start date: 2013-09-16
Primary completion: 2014-09-09
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.